Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDL-Atherosclerosis Treatment Study (HATS)
NCT00000553Phase 3Completed
- Sponsor
- University of Washington
- Start
- Sep 1994
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of simvastatin and niacin in coronary heart disease (CHD) (4 arms), sponsored by University of Washington. Primary endpoint: Average change in proximal obstructive disease at 2.5 years. Started Sep 1994; status: completed.
02
Drugs
simvastatinniacin
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00000553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000553.